207 related articles for article (PubMed ID: 1354869)
1. [Drug resistance genes].
Marie JP
Presse Med; 1992 Jun; 21(22):1033-7. PubMed ID: 1354869
[TBL] [Abstract][Full Text] [Related]
2. [Multiple drug resistance: a problem in cancer chemotherapy].
Lizano Soberón M; Barrera Rodríquez R
Rev Invest Clin; 1993; 45(5):481-92. PubMed ID: 7907810
[TBL] [Abstract][Full Text] [Related]
3. Molecular targets in oncology: implications of the multidrug resistance gene.
Lum BL; Gosland MP; Kaubisch S; Sikic BI
Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
[TBL] [Abstract][Full Text] [Related]
4. Keynote address: multidrug resistance: a pleiotropic response to cytotoxic drugs.
Fairchild CR; Cowan KH
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):361-7. PubMed ID: 1671383
[TBL] [Abstract][Full Text] [Related]
5. P-glycoproteins in pathology: the multidrug resistance gene family in humans.
Weinstein RS; Kuszak JR; Kluskens LF; Coon JS
Hum Pathol; 1990 Jan; 21(1):34-48. PubMed ID: 1967244
[TBL] [Abstract][Full Text] [Related]
6. [GP-170 glycoprotein and resistance to chemotherapy].
Lazarowski AJ
Medicina (B Aires); 1991; 51(3):279-80. PubMed ID: 1687986
[No Abstract] [Full Text] [Related]
7. Clinical significance of multiple drug resistance in human cancers.
Bénard J; Bourhis J; Riou G
Anticancer Res; 1990; 10(5A):1297-302. PubMed ID: 1978633
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic, multidrug-resistant phenotype and P-glycoprotein: a review.
Ban T
Chemotherapy; 1992; 38(3):191-6. PubMed ID: 1355045
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance.
Tiirikainen MI; Krusius T
Ann Med; 1991; 23(5):509-20. PubMed ID: 1684512
[TBL] [Abstract][Full Text] [Related]
10. [Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers].
Bourhis J; Riou G; Bénard J
Bull Cancer; 1990; 77(10):957-65. PubMed ID: 1979014
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
Nooter K; Stoter G
Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
Pasman PC; Schouten HC
Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance due to P-glycoprotein.
Burt RK; Fojo AT; Thorgeirsson SS
Hosp Pract (Off Ed); 1990 Apr; 25(4):67-72, 74, 77. PubMed ID: 1969865
[TBL] [Abstract][Full Text] [Related]
14. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression.
Nobili S; Landini I; Mazzei T; Mini E
Med Res Rev; 2012 Nov; 32(6):1220-62. PubMed ID: 21374643
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance.
Moscow JA; Cowan KH
J Natl Cancer Inst; 1988 Mar; 80(1):14-20. PubMed ID: 2892943
[TBL] [Abstract][Full Text] [Related]
16. [The multidrug-resistance gene MDR1].
Ueda K; Komano T
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2858-62. PubMed ID: 2902831
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of multidrug resistance of tumor cells.
Kane SE; Pastan I; Gottesman MM
J Bioenerg Biomembr; 1990 Aug; 22(4):593-618. PubMed ID: 1977744
[TBL] [Abstract][Full Text] [Related]
18. P glycoprotein (P-gp) and drug resistance--time for reappraisal?
Kaye SB
Br J Cancer; 1993 Apr; 67(4):641-3. PubMed ID: 8097103
[No Abstract] [Full Text] [Related]
19. Multidrug resistance (MDR) genes in haematological malignancies.
Nooter K; Sonneveld P
Cytotechnology; 1993; 12(1-3):213-30. PubMed ID: 7765326
[TBL] [Abstract][Full Text] [Related]
20. [Glycoprotein in multidrug-resistant malignancies--clinical implications].
Ellis A; Lishner M; Manor J; Ravid M
Harefuah; 1994 Mar; 126(6):334-7. PubMed ID: 7910806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
